OM
OKYO

Opaleye Management’s OKYO Pharma OKYO Stock Holding History

Opaleye Management’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$563K Buy
+375,204
New +$601K 0.05% 56

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management's OKYO Position: Q2 2026 in Review

Opaleye Management opened a new position in OKYO Pharma (OKYO) in Q2 2026: 375,204 shares worth $563K. The stake represents 0.05% of the portfolio and ranks #56 among its holdings.

19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

  • Opaleye Management held 375,204 shares of OKYO Pharma worth $563K as of Q2 2026.
  • OKYO Pharma was a new Opaleye Management position in Q2 2026.
  • OKYO Pharma made up 0.05% of Opaleye Management's portfolio in Q2 2026, its #56 holding.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Opaleye Management's 13F filing for Q2 2026, filed 14 Aug 2026.